TuHURA Biosciences, Inc.
HURA
$2.01
-$0.11-5.19%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 43.77% | 69.46% | 105.93% | 106.61% | 62.17% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 40.43% | 53.33% | 65.67% | 73.62% | 44.86% |
| Operating Income | -40.43% | -53.33% | -65.67% | -73.62% | -44.86% |
| Income Before Tax | -10.30% | -31.57% | -38.60% | -59.44% | -60.20% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -10.30% | -31.57% | -38.60% | -59.44% | -60.20% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -10.30% | -31.57% | -38.60% | -59.44% | -60.20% |
| EBIT | -40.43% | -53.33% | -65.67% | -73.62% | -44.86% |
| EBITDA | -40.47% | -53.69% | -66.38% | -74.78% | -45.82% |
| EPS Basic | 49.38% | 52.58% | 58.34% | 52.74% | -22.15% |
| Normalized Basic EPS | 36.10% | 51.66% | 58.95% | 57.21% | -2.63% |
| EPS Diluted | 49.38% | 52.58% | 58.34% | 52.77% | -22.04% |
| Normalized Diluted EPS | 36.10% | 51.66% | 58.95% | 57.21% | -2.63% |
| Average Basic Shares Outstanding | 64.65% | 96.66% | 156.69% | 69.07% | 49.69% |
| Average Diluted Shares Outstanding | 64.65% | 96.66% | 156.69% | 69.07% | 49.69% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -0.81% | -2.06% | -- | -- | -- |